查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1635820

家庭分子檢測市場：全球產業分析、市場規模、佔有率、成長、趨勢與未來預測（2025-2032）

At-Home Molecular Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 221 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發佈了一份關於全球家庭分子檢測市場的詳細報告。該報告對市場推動因素、趨勢、機會和課題等關鍵市場動態進行了全面的分析，並對市場結構提供了深入的見解。

重要見解

  • 家庭分子檢測市場規模（2025年）：118億美元
  • 市場規模預測（價值基礎，2032 年）：178 億美元
  • 全球市場成長率（CAGR，2025-2032）：6.2%

家庭分子檢測市場：分析範圍

家用分子檢測市場包括各種診斷試劑盒和解決方案，可在家中進行檢測以檢測特定的生物標記、病原體和遺傳狀況。這些產品的設計著重於便利性、準確性和易用性，可滿足消費者的各種需求，包括疾病診斷、遺傳易感性測試和健康監測。該市場服務於不同的領域，包括直接面向消費者的管道、零售商、線上平台和醫療保健提供者。這一增長的推動因素包括：對便捷且可獲得的診斷解決方案的需求不斷增長、分子檢測技術的進步以及慢性病和傳染病患者病率不斷上升。

市場成長動力：

有幾個關鍵因素正在推動全球家庭分子檢測市場的發展。人們對預防保健和早期疾病診斷的認識不斷提高，推動了家庭分子檢測解決方案的採用。聚合酶鍊式反應（PCR）和等溫擴增技術等分子診斷技術的進步使得用戶友好且準確的檢測試劑盒的開發成為可能。此外，生活方式疾病的日益流行和個人化醫療需求的不斷增長也刺激了市場的擴張。加強研發活動以及測試格式和應用的創新，透過為具有不同醫療需求的消費者提供客製化解決方案，進一步促進市場擴張。

市場阻礙因素：

儘管成長前景看好，但家庭分子檢測市場面臨著與先進診斷試劑盒成本高以及對某些家庭檢測的準確性和可靠性的擔憂有關的課題。新興市場消費者認知度低以及產品審批監管障礙可能會阻礙市場成長。此外，分子檢測過程的複雜性可能會阻礙不熟悉診斷工具的消費者採用。解決這些問題需要持續投資於產品創新、消費者教育，並努力簡化測試程序，同時保持準確性和可負擔性。

市場機會：

由於遠距醫療和數位健康平台的日益普及，以及與家庭分子檢測解決方案的無縫集成，市場提供了巨大的機會。基於 CRISPR 的診斷和即時核酸檢測等尖端技術的開發正在滿足對快速準確結果日益增長的需求。擴大銷售網絡，尤其是透過線上管道，可以為公司提供更廣泛的市場覆蓋率，並提高最終用戶的可訪問性。與醫療保健提供者建立策略合作夥伴關係以及對資料安全和隱私的投資對於利用新的商機和在這個不斷發展的市場中保持消費者信任至關重要。

本報告回答的關鍵問題

  • 推動全球家庭分子檢測市場成長的關鍵因素有哪些？
  • 哪些類型的家庭分子測試在不同消費者群體中廣泛採用？
  • 技術進步如何影響家庭分子偵測市場的競爭格局？
  • 家庭分子檢測市場的主要參與者是誰？他們採取了什麼策略來保持競爭力？
  • 全球家庭分子檢測市場的新興趨勢和未來前景如何？

目錄

第1章 執行摘要

第2章 市場概況

  • 市場範圍和定義
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 任務
    • 主要趨勢
  • 產品生命週期分析
  • 首頁 分子檢測市場：價值鏈
    • 原材料供應商名單
    • 製造商名單
    • 經銷商名單
    • 用途一覽
    • 獲利能力分析
  • 波特五力分析
  • 地緣政治緊張局勢：對市場的影響
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP增長展望
    • 全球母公司市場概覽
  • 預測因素：相關性和影響
  • 監管和技術格局

第 3 章 全球家庭分子檢測市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

  • 主要亮點
    • 市場規模預測（以數量為基礎）
    • 市場規模及年成長率
    • 絕對的獲利機會
  • 市場規模分析及預測（價值（十億美元））
    • 歷史市場規模分析（2019-2023）
    • 目前市場規模預測（2025-2032）
  • 全球家庭分子檢測市場展望（依產品劃分）
    • 簡介/主要發現
    • 按產品劃分的歷史市場規模表現（價值（十億美元）和數量，2019 年至 2023 年）
    • 目前市場規模預測（按產品劃分，價值（十億美元）和數量，2025 年至 2032 年）
      • 卡式磁帶
      • 條
      • 測試板
      • 浸卡
      • Midstream
      • 其他
  • 按產品進行市場吸引力分析
  • 全球家庭分子檢測市場前景（按檢測類型）
    • 簡介/主要發現
    • 按測試類型劃分的歷史市場規模表現（價值（十億美元）和數量，2019 年至 2023 年）
    • 按測試類型劃分的當前市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
      • 懷孕測試
      • 艾滋病毒檢測
      • 糖尿病
      • 感染
      • 葡萄糖測試
      • 排卵預測測試
      • 藥物濫用測試
      • 其他
  • 按測試類型進行市場吸引力分析
  • 全球家庭分子檢測市場展望（按樣本類型）
    • 簡介/主要發現
    • 按樣本類型劃分的歷史市場規模表現（價值（十億美元）和數量，2019-2023 年）
    • 按樣本類型劃分的當前市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
      • 尿
      • 血液
      • 唾液
      • 其他
  • 依樣本類型進行市場吸引力分析
  • 全球家庭分子檢測市場前景（依分銷管道劃分）
    • 簡介/主要發現
    • 按分銷管道劃分的歷史市場規模表現（價值（十億美元）和數量，2019-2023 年）
    • 按分銷管道劃分的當前市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
      • 零售藥店
      • 藥店
      • 超市/大賣場
      • 網上藥店
  • 市場吸引力分析：按分銷渠道

第 4 章 全球家庭分子檢測市場按地區展望

  • 主要亮點
  • 按地區劃分的歷史市場規模分析（價值（十億美元）和數量，2019 年至 2023 年）
  • 各地區目前市場規模預測（價值（十億美元）和數量，2025 年至 2032 年）
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東/非洲
  • 市場吸引力分析：按地區

第 5 章 北美家庭分子檢測市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

第 6 章 歐洲家庭分子檢測市場展望：歷史（2019-2023）與預測（2025-2032）

第 7 章 東亞家庭分子檢測市場展望：歷史資料（2019-2023 年）與預測（2025-2032 年）

第 8 章 南亞和大洋洲家庭分子檢測市場展望：歷史（2019-2023 年）和預測（2025-2032 年）

第 9 章 拉丁美洲家庭分子檢測市場展望：歷史（2019-2023 年）與預測（2025-2032 年）

第 10 章中東和非洲家庭分子檢測市場展望：歷史（2019-2023 年）和預測（2025-2032 年）

第11章 競爭格局

  • 市場佔有率分析（2024 年）
  • 市場結構
    • 競爭加劇地圖：按市場劃分
    • 比賽儀表板
    • 產品生產能力（表觀價值）：依產品分類
  • 公司簡介（詳細資料：概述、財務狀況、策略、最新發展）
    • Abbott
    • ACON Laboratories, Inc.
    • Rapikit
    • Becton and Dickinson
    • Cardinal Health
    • B. Braun Melsungen AG
    • Piramal Enterprises Ltd.
    • Siemens Healthcare GmbH
    • Quidel Corporation
    • Bionime Corporation
    • SA Scientific
    • ARKRAY USA, Inc.
    • Nova Biomedical
    • AdvaCare Pharma
    • AccuBioTech Co., Ltd.
    • Atlas Medical UK
    • TaiDoc Technology Corporation
    • Dragerwerk AG & Co. KGaA
    • F. Hoffmann-La Roche Ltd
    • Sensing Self
    • PTE. Ltd
    • Atomo Diagnostics
    • Mankind Pharma

第 12 章 附錄

  • 分析方法
  • 分析前提條件
  • 縮寫
簡介目錄
Product Code: PMRREP33685

Persistence Market Research has recently published an extensive report on the global At-Home Molecular Testing Market. This report offers a comprehensive analysis of the key market dynamics, including drivers, trends, opportunities, and challenges, providing deep insights into the market structure.

Key Insights:

  • At-Home Molecular Testing Market Size (2025E): USD 11.8 Bn
  • Projected Market Value (2032F): USD 17.8 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 6.2%

At-Home Molecular Testing Market - Report Scope:

The At-Home Molecular Testing Market encompasses a range of diagnostic kits and solutions that allow individuals to perform tests at home for detecting specific biomarkers, pathogens, or genetic conditions. These products are designed for convenience, accuracy, and ease of use, catering to a wide variety of consumer needs, including disease diagnosis, genetic predisposition testing, and health monitoring. The market serves diverse segments, including direct-to-consumer channels, retail outlets, online platforms, and healthcare providers. Growth is driven by increasing demand for convenient and accessible diagnostic solutions, technological advancements in molecular testing, and the rising prevalence of chronic and infectious diseases.

Market Growth Drivers:

Several key factors are driving the global At-Home Molecular Testing Market. The rising awareness of preventive healthcare and early disease diagnosis is boosting the adoption of at-home molecular testing solutions. Technological advancements in molecular diagnostics, such as polymerase chain reaction (PCR) and isothermal amplification techniques, have enabled the development of user-friendly and accurate testing kits. Additionally, the increasing prevalence of lifestyle diseases, coupled with the growing demand for personalized medicine, is fueling market expansion. Enhanced research and development activities, along with innovations in test formats and applications, further contribute to market growth by offering tailored solutions for consumers with diverse healthcare needs.

Market Restraints:

Despite promising growth prospects, the At-Home Molecular Testing Market faces challenges related to the high costs of advanced diagnostic kits and concerns regarding the accuracy and reliability of certain at-home tests. Limited consumer awareness in developing regions and regulatory hurdles for product approval can hinder market growth. Additionally, the complexity of molecular testing processes may deter adoption among consumers unfamiliar with diagnostic tools. Addressing these issues requires continuous investment in product innovation, consumer education, and efforts to simplify test procedures while maintaining accuracy and affordability.

Market Opportunities:

The market presents significant opportunities driven by the increasing adoption of telemedicine and digital health platforms, which integrate seamlessly with at-home molecular testing solutions. The development of advanced technologies, such as CRISPR-based diagnostics and point-of-care nucleic acid testing, caters to the growing need for rapid and accurate results. Expanding distribution networks, particularly through online channels, provides companies with broader market reach and enhances accessibility for end-users. Strategic collaborations with healthcare providers and investments in data security and privacy are essential for capitalizing on emerging opportunities and maintaining consumer trust in this evolving market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the At-Home Molecular Testing Market globally?
  • Which types of at-home molecular tests are leading adoption across different consumer segments?
  • How are technological advancements influencing the competitive landscape of the At-Home Molecular Testing Market?
  • Who are the key players in the At-Home Molecular Testing Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global At-Home Molecular Testing Market?

Competitive Intelligence and Business Strategy:

Leading players in the global At-Home Molecular Testing Market, including Abbott Laboratories, Thermo Fisher Scientific, and F. Hoffmann-La Roche AG, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, such as multiplexed tests and portable devices. Collaborations with telehealth providers, distributors, and e-commerce platforms facilitate market access and promote new product adoption. Emphasis on consumer education, high-quality products, and targeted marketing strategies fosters market growth and enhances brand loyalty in the dynamic At-Home Molecular Testing Market landscape.

Key Companies Profiled:

  • Abbott
  • ACON Laboratories, Inc.
  • Rapikit
  • Becton and Dickinson
  • Cardinal Health
  • B. Braun Melsungen AG
  • Piramal Enterprises Ltd.
  • Siemens Healthcare GmbH
  • Quidel Corporation
  • Bionime Corporation
  • SA Scientific
  • ARKRAY USA, Inc.

At-Home Molecular Testing Market Industry Segmentation:

By Product:

  • Cassettes
  • Strips
  • Test Panels
  • Dip Cards
  • Midstream
  • Others

By Test Type:

  • Pregnancy Tests
  • HIV Tests
  • Diabetes
  • Infectious Diseases
  • Glucose Tests
  • Ovulation Predictor Tests
  • Drug Abuse Tests
  • Others

By Sample Type:

  • Urine
  • Blood
  • Saliva
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Drug Stores
  • Supermarkets/Hypermarkets
  • Online Pharmacies

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global At-home Molecular Testing Market Snapshot, 2025 - 2032
  • 1.2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. At-home Molecular Testing Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Bn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2019 - 2023
    • 3.2.2. Current Market Size Forecast, 2025 - 2032
  • 3.3. Global At-home Molecular Testing Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019 - 2023
    • 3.3.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
      • 3.3.3.1. Cassettes
      • 3.3.3.2. Strips
      • 3.3.3.3. Test Panels
      • 3.3.3.4. Dip Cards
      • 3.3.3.5. Midstreams
      • 3.3.3.6. Others
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global At-home Molecular Testing Market Outlook: Test Type
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Test Type, 2019 - 2023
    • 3.5.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
      • 3.5.3.1. Pregnancy Tests
      • 3.5.3.2. HIV Tests
      • 3.5.3.3. Diabetes
      • 3.5.3.4. Infectious Diseases
      • 3.5.3.5. Glucose Tests
      • 3.5.3.6. Ovulation Predictor Tests
      • 3.5.3.7. Drug Abuse Tests
      • 3.5.3.8. Others
  • 3.6. Market Attractiveness Analysis: Test Type
  • 3.7. Global At-home Molecular Testing Market Outlook: Sample Type
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Sample Type, 2019 - 2023
    • 3.7.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
      • 3.7.3.1. Urine
      • 3.7.3.2. Blood
      • 3.7.3.3. Saliva
      • 3.7.3.4. Others
  • 3.8. Market Attractiveness Analysis: Sample Type
  • 3.9. Global At-home Molecular Testing Market Outlook: Distribution Channel
    • 3.9.1. Introduction / Key Findings
    • 3.9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Distribution Channel, 2019 - 2023
    • 3.9.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
      • 3.9.3.1. Retail Pharmacies
      • 3.9.3.2. Drug Stores
      • 3.9.3.3. Supermarkets/Hypermarkets
      • 3.9.3.4. Online Pharmacies
  • 3.10. Market Attractiveness Analysis: Distribution Channel

4. Global At-home Molecular Testing Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019 - 2023
  • 4.3. Current Market Size (US$ Bn) and Volume (Units) Forecast By Region, 2025 - 2032
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By Test Type
    • 5.3.4. By Sample Type
    • 5.3.5. By Distribution Channel
  • 5.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 5.5.1. Cassettes
    • 5.5.2. Strips
    • 5.5.3. Test Panels
    • 5.5.4. Dip Cards
    • 5.5.5. Midstreams
    • 5.5.6. Others
  • 5.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 5.6.1. Pregnancy Tests
    • 5.6.2. HIV Tests
    • 5.6.3. Diabetes
    • 5.6.4. Infectious Diseases
    • 5.6.5. Glucose Tests
    • 5.6.6. Ovulation Predictor Tests
    • 5.6.7. Drug Abuse Tests
    • 5.6.8. Others
  • 5.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 5.7.1. Urine
    • 5.7.2. Blood
    • 5.7.3. Saliva
    • 5.7.4. Others
  • 5.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 5.8.1. Retail Pharmacies
    • 5.8.2. Drug Stores
    • 5.8.3. Supermarkets/Hypermarkets
    • 5.8.4. Online Pharmacies
  • 5.9. Market Attractiveness Analysis

6. Europe At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By Test Type
    • 6.3.4. By Sample Type
    • 6.3.5. By Distribution Channel
  • 6.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 6.5.1. Cassettes
    • 6.5.2. Strips
    • 6.5.3. Test Panels
    • 6.5.4. Dip Cards
    • 6.5.5. Midstreams
    • 6.5.6. Others
  • 6.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 6.6.1. Pregnancy Tests
    • 6.6.2. HIV Tests
    • 6.6.3. Diabetes
    • 6.6.4. Infectious Diseases
    • 6.6.5. Glucose Tests
    • 6.6.6. Ovulation Predictor Tests
    • 6.6.7. Drug Abuse Tests
    • 6.6.8. Others
  • 6.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 6.7.1. Urine
    • 6.7.2. Blood
    • 6.7.3. Saliva
    • 6.7.4. Others
  • 6.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 6.8.1. Retail Pharmacies
    • 6.8.2. Drug Stores
    • 6.8.3. Supermarkets/Hypermarkets
    • 6.8.4. Online Pharmacies
  • 6.9. Market Attractiveness Analysis

7. East Asia At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By Test Type
    • 7.3.4. By Sample Type
    • 7.3.5. By Distribution Channel
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 7.5.1. Cassettes
    • 7.5.2. Strips
    • 7.5.3. Test Panels
    • 7.5.4. Dip Cards
    • 7.5.5. Midstreams
    • 7.5.6. Others
  • 7.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 7.6.1. Pregnancy Tests
    • 7.6.2. HIV Tests
    • 7.6.3. Diabetes
    • 7.6.4. Infectious Diseases
    • 7.6.5. Glucose Tests
    • 7.6.6. Ovulation Predictor Tests
    • 7.6.7. Drug Abuse Tests
    • 7.6.8. Others
  • 7.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 7.7.1. Urine
    • 7.7.2. Blood
    • 7.7.3. Saliva
    • 7.7.4. Others
  • 7.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 7.8.1. Retail Pharmacies
    • 7.8.2. Drug Stores
    • 7.8.3. Supermarkets/Hypermarkets
    • 7.8.4. Online Pharmacies
  • 7.9. Market Attractiveness Analysis

8. South Asia & Oceania At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By Test Type
    • 8.3.4. By Sample Type
    • 8.3.5. By Distribution Channel
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 8.5.1. Cassettes
    • 8.5.2. Strips
    • 8.5.3. Test Panels
    • 8.5.4. Dip Cards
    • 8.5.5. Midstreams
    • 8.5.6. Others
  • 8.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 8.6.1. Pregnancy Tests
    • 8.6.2. HIV Tests
    • 8.6.3. Diabetes
    • 8.6.4. Infectious Diseases
    • 8.6.5. Glucose Tests
    • 8.6.6. Ovulation Predictor Tests
    • 8.6.7. Drug Abuse Tests
    • 8.6.8. Others
  • 8.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 8.7.1. Urine
    • 8.7.2. Blood
    • 8.7.3. Saliva
    • 8.7.4. Others
  • 8.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 8.8.1. Retail Pharmacies
    • 8.8.2. Drug Stores
    • 8.8.3. Supermarkets/Hypermarkets
    • 8.8.4. Online Pharmacies
  • 8.9. Market Attractiveness Analysis

9. Latin America At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By Test Type
    • 9.3.4. By Sample Type
    • 9.3.5. By Distribution Channel
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 9.5.1. Cassettes
    • 9.5.2. Strips
    • 9.5.3. Test Panels
    • 9.5.4. Dip Cards
    • 9.5.5. Midstreams
    • 9.5.6. Others
  • 9.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 9.6.1. Pregnancy Tests
    • 9.6.2. HIV Tests
    • 9.6.3. Diabetes
    • 9.6.4. Infectious Diseases
    • 9.6.5. Glucose Tests
    • 9.6.6. Ovulation Predictor Tests
    • 9.6.7. Drug Abuse Tests
    • 9.6.8. Others
  • 9.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 9.7.1. Urine
    • 9.7.2. Blood
    • 9.7.3. Saliva
    • 9.7.4. Others
  • 9.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 9.8.1. Retail Pharmacies
    • 9.8.2. Drug Stores
    • 9.8.3. Supermarkets/Hypermarkets
    • 9.8.4. Online Pharmacies
  • 9.9. Market Attractiveness Analysis

10. Middle East & Africa At-home Molecular Testing Market Outlook: Historical (2019 - 2023) and Forecast (2025 - 2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market, 2019 - 2023
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By Test Type
    • 10.3.4. By Sample Type
    • 10.3.5. By Distribution Channel
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Forecast By Country, 2025 - 2032
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Bn) and Volume (Units) Forecast By Product, 2025 - 2032
    • 10.5.1. Cassettes
    • 10.5.2. Strips
    • 10.5.3. Test Panels
    • 10.5.4. Dip Cards
    • 10.5.5. Midstreams
    • 10.5.6. Others
  • 10.6. Current Market Size (US$ Bn) and Volume (Units) Forecast By Test Type, 2025 - 2032
    • 10.6.1. Pregnancy Tests
    • 10.6.2. HIV Tests
    • 10.6.3. Diabetes
    • 10.6.4. Infectious Diseases
    • 10.6.5. Glucose Tests
    • 10.6.6. Ovulation Predictor Tests
    • 10.6.7. Drug Abuse Tests
    • 10.6.8. Others
  • 10.7. Current Market Size (US$ Bn) and Volume (Units) Forecast By Sample Type, 2025 - 2032
    • 10.7.1. Urine
    • 10.7.2. Blood
    • 10.7.3. Saliva
    • 10.7.4. Others
  • 10.8. Current Market Size (US$ Bn) and Volume (Units) Forecast By Distribution Channel, 2025 - 2032
    • 10.8.1. Retail Pharmacies
    • 10.8.2. Drug Stores
    • 10.8.3. Supermarkets/Hypermarkets
    • 10.8.4. Online Pharmacies
  • 10.9. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2024
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Dashboard
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Abbott
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. ACON Laboratories, Inc.
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Rapikit
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Becton and Dickinson
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Cardinal Health
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. B. Braun Melsungen AG
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Piramal Enterprises Ltd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Siemens Healthcare GmbH
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Quidel Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Bionime Corporation
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. SA Scientific
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy
    • 11.3.12. ARKRAY USA, Inc.
      • 11.3.12.1. Overview
      • 11.3.12.2. Segments and Product
      • 11.3.12.3. Key Financials
      • 11.3.12.4. Market Developments
      • 11.3.12.5. Market Strategy
    • 11.3.13. Nova Biomedical
      • 11.3.13.1. Overview
      • 11.3.13.2. Segments and Product
      • 11.3.13.3. Key Financials
      • 11.3.13.4. Market Developments
      • 11.3.13.5. Market Strategy
    • 11.3.14. AdvaCare Pharma
      • 11.3.14.1. Overview
      • 11.3.14.2. Segments and Product
      • 11.3.14.3. Key Financials
      • 11.3.14.4. Market Developments
      • 11.3.14.5. Market Strategy
    • 11.3.15. AccuBioTech Co., Ltd.
      • 11.3.15.1. Overview
      • 11.3.15.2. Segments and Product
      • 11.3.15.3. Key Financials
      • 11.3.15.4. Market Developments
      • 11.3.15.5. Market Strategy
    • 11.3.16. Atlas Medical UK
      • 11.3.16.1. Overview
      • 11.3.16.2. Segments and Product
      • 11.3.16.3. Key Financials
      • 11.3.16.4. Market Developments
      • 11.3.16.5. Market Strategy
    • 11.3.17. TaiDoc Technology Corporation
      • 11.3.17.1. Overview
      • 11.3.17.2. Segments and Product
      • 11.3.17.3. Key Financials
      • 11.3.17.4. Market Developments
      • 11.3.17.5. Market Strategy
    • 11.3.18. Dragerwerk AG & Co. KGaA
      • 11.3.18.1. Overview
      • 11.3.18.2. Segments and Product
      • 11.3.18.3. Key Financials
      • 11.3.18.4. Market Developments
      • 11.3.18.5. Market Strategy
    • 11.3.19. F. Hoffmann-La Roche Ltd
      • 11.3.19.1. Overview
      • 11.3.19.2. Segments and Product
      • 11.3.19.3. Key Financials
      • 11.3.19.4. Market Developments
      • 11.3.19.5. Market Strategy
    • 11.3.20. Sensing Self
      • 11.3.20.1. Overview
      • 11.3.20.2. Segments and Product
      • 11.3.20.3. Key Financials
      • 11.3.20.4. Market Developments
      • 11.3.20.5. Market Strategy
    • 11.3.21. PTE. Ltd
      • 11.3.21.1. Overview
      • 11.3.21.2. Segments and Product
      • 11.3.21.3. Key Financials
      • 11.3.21.4. Market Developments
      • 11.3.21.5. Market Strategy
    • 11.3.22. Atomo Diagnostics
      • 11.3.22.1. Overview
      • 11.3.22.2. Segments and Product
      • 11.3.22.3. Key Financials
      • 11.3.22.4. Market Developments
      • 11.3.22.5. Market Strategy
    • 11.3.23. Mankind Pharma
      • 11.3.23.1. Overview
      • 11.3.23.2. Segments and Product
      • 11.3.23.3. Key Financials
      • 11.3.23.4. Market Developments
      • 11.3.23.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations